In the fourth quarter of 2012, USV will launch Vibact IBS based on the probiotic formulation Probi Digestis.
Probi’s capsules based on the Lactobacillus plantarum 299v strain, will be launched under the Vibact IBS brand.
Vibact IBS will specifically target IBS symptoms like bloating, flatulence and pain.
Probi CEO Michael Oredsson said USV is the best probiotic partner in the consumer healthcare sector in India.
"We are very pleased to partner with USV and to be able to launch our probiotic formulation Probi Digestis in a market with significant growth potential," Oredsson added.